Where This Began
Russell's viper venom is extraordinarily complex, a mixture of many different toxins. For a long time that complexity worried me. Would we ever be able to make drugs or antibodies specific enough to treat a Russell's viper bite well? Neutralising every single component seemed close to impossible. What we found in the end changed the way I think about treating snakebite.
The Big Idea: Toxins Working Together
It is easy to picture snake venom as a random mix of toxins, each doing its own damage. But in the lab, my team and I kept seeing something different: much of the venom's power comes from how its components work together. Acting in combination, these toxins do far more harm than they ever could separately. We call this "toxin synergy."
Taking the Venom Apart
To work out how this happens, we took the whole venom apart. We separated Russell's viper venom into its individual components, then measured how much damage each piece did on its own, and compared that with what happened when we put them back together.
The Scissors and the Detergent
Doing this, we found a striking partnership between two families of toxins in the venom:
- SVMPs (snake venom metalloproteinases): think of these as microscopic scissors. They cut through tissue and blood vessels, causing internal bleeding.
- PLA2s (phospholipases A2): these act more like detergents, breaking down the protective outer walls of our cells.
Our data showed that when the scissors and the detergents act together, they cause far more cell damage and bleeding than either does alone. Each one makes the other more dangerous.
The Turning Point
This is where it became interesting. It suggested we might not need to neutralise every toxin to stop the venom's worst effects.
We showed that blocking just one of these key toxins with a specific inhibitor is enough to break the partnership. Once we disrupted it, the venom's overall lethal effect dropped sharply, which for us was a genuinely exciting result.
Why This Matters
At the moment, snakebite is treated mainly with traditional antivenoms, which can be expensive, hard to get hold of, and limited in how well they work. This is why the finding makes us hopeful.
It suggests that new, targeted drugs, such as combination therapies or small-molecule inhibitors that break up this toxin synergy, could be an effective way to neutralise the venom, limit tissue damage, and save lives. I am proud of my team for the work that got us here.
Paper: Rudresha GV, Bhatia S, Samanta A, Naik M, Sunagar K. Dissecting Daboia: Investigating synergistic effects of Russell's viper venom toxins .
Comments